RU2115651C1 - N(гетеро)-арил-n(гетеро)-тетралин-алкил-пиперазины, способ их получения - Google Patents
N(гетеро)-арил-n(гетеро)-тетралин-алкил-пиперазины, способ их получения Download PDFInfo
- Publication number
- RU2115651C1 RU2115651C1 RU94046220A RU94046220A RU2115651C1 RU 2115651 C1 RU2115651 C1 RU 2115651C1 RU 94046220 A RU94046220 A RU 94046220A RU 94046220 A RU94046220 A RU 94046220A RU 2115651 C1 RU2115651 C1 RU 2115651C1
- Authority
- RU
- Russia
- Prior art keywords
- piperazine
- methoxy
- general formula
- compound
- propyl
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI92A001569 | 1992-06-26 | ||
ITM192A001569 | 1992-06-26 | ||
ITMI921569A IT1255178B (it) | 1992-06-26 | 1992-06-26 | N(eter0)-aril-n(etero)-tetralinalchil piperazine aventi attivita' serotoninergica,dopaminergica e adrenergica |
Publications (2)
Publication Number | Publication Date |
---|---|
RU94046220A RU94046220A (ru) | 1996-09-27 |
RU2115651C1 true RU2115651C1 (ru) | 1998-07-20 |
Family
ID=11363580
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU94046220A RU2115651C1 (ru) | 1992-06-26 | 1993-06-22 | N(гетеро)-арил-n(гетеро)-тетралин-алкил-пиперазины, способ их получения |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0647222A1 (it) |
JP (1) | JPH07508514A (it) |
KR (1) | KR950702195A (it) |
AU (1) | AU670444B2 (it) |
CA (1) | CA2137685A1 (it) |
FI (1) | FI945997A0 (it) |
HU (1) | HUT71405A (it) |
IL (1) | IL106124A (it) |
IT (1) | IT1255178B (it) |
NZ (1) | NZ253689A (it) |
RU (1) | RU2115651C1 (it) |
WO (1) | WO1994000441A1 (it) |
ZA (1) | ZA934472B (it) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2641648C1 (ru) * | 2009-12-04 | 2018-01-19 | Суновион Фармасьютикалз, Инк. | Полициклические соединения и способы их применения |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0737189B1 (en) * | 1993-12-28 | 1999-07-28 | PHARMACIA & UPJOHN COMPANY | Heterocyclic compounds for the treatment of cns and cardiovascular disorders |
FR2716193B1 (fr) * | 1994-02-16 | 1996-04-05 | Synthelabo | Dérivés de 1[2-(1h-inden-3-yl)ethyl]-4-(naphtalen-1-yl)piperazine, leur préparation et leur application en thérapeutique. |
US5472966A (en) * | 1995-03-29 | 1995-12-05 | Bristol-Myers Squibb Company | Antidepressant heteroarylaminoalkyl derivatives of naphthyl-monazines |
FR2737723B1 (fr) * | 1995-08-09 | 1997-09-05 | Synthelabo | Derives de 1-(2-(1h-inden-3-yl)ethyl)-4-(naphtalen-1-yl)- piperazine, leur preparation et leur application en therapeutique |
TW407153B (en) * | 1997-10-27 | 2000-10-01 | Nippon Kayaku Kk | Imidazole compounds and their use |
WO2001049679A1 (en) * | 1999-12-30 | 2001-07-12 | H. Lundbeck A/S | 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives |
KR100496874B1 (ko) * | 2003-07-03 | 2005-06-22 | 주식회사 엘지화학 | 초임계 이산화탄소를 이용한 폴리메틸메타크릴레이트제조방법 |
US7423176B2 (en) | 2004-04-13 | 2008-09-09 | Cephalon, Inc. | Bicyclic aromatic sulfinyl derivatives |
EP1829869A1 (en) * | 2006-03-02 | 2007-09-05 | Laboratorios Del Dr. Esteve, S.A. | 4,5,6,7-Tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands |
JP2019523279A (ja) | 2016-07-29 | 2019-08-22 | サノビオン ファーマシューティカルズ インクSunovion Pharmaceuticals Inc. | 化合物および組成物ならびにそれらの使用 |
MA45857A (fr) | 2016-07-29 | 2021-05-19 | Sunovion Pharmaceuticals Inc | Composés et compositions, et utilisations associées |
AU2018220509B2 (en) | 2017-02-16 | 2022-04-28 | Sunovion Pharmaceuticials Inc. | Methods of treating schizophrenia |
CA3070993A1 (en) | 2017-08-02 | 2019-02-07 | Sunovion Pharmaceuticals Inc. | Isochroman compounds and uses thereof |
KR20200122345A (ko) | 2018-02-16 | 2020-10-27 | 선오비온 파마슈티컬스 인코포레이티드 | 염, 결정 형태 및 이들의 제조 방법 |
MX2021010880A (es) | 2019-03-14 | 2022-01-18 | Sunovion Pharmaceuticals Inc | Sales de un compuesto de isocromanilo y formas cristalinas, procesos de preparacion, usos terapeuticos y composiciones farmaceuticas de las mismas. |
CA3180115A1 (en) | 2020-04-14 | 2021-10-21 | Sunovion Pharmaceuticals Inc. | (s)-(4,5-dihydro-7h-thieno[2,3-c]pyran-7-yl)-n-methylmethanamine for treating neurological and psychiatric disorders |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2235597A1 (de) * | 1972-07-20 | 1974-01-31 | Boehringer Mannheim Gmbh | 1-eckige klammer auf 3-(5,6,7,8tetrahydronaphth-1-yl-oxy) -propyl eckige klammer zu -piperazin-derivate und verfahren zu ihrer herstellung |
US4130646A (en) * | 1975-07-25 | 1978-12-19 | E. R. Squibb & Sons, Inc. | 1,2,3,4-Tetrahydro-2-((4-(phenyl)-1-piperazinyl)methyl)-1-naphthalenols and derivatives and analogs thereof |
GB2093837B (en) * | 1981-03-02 | 1985-04-24 | Abbott Lab | Aminoalkyl subsituted 1,2,3,4-tetrahydronaphtalenes |
US4473586A (en) * | 1982-05-03 | 1984-09-25 | Abbott Laboratories | Aminoalkyl dihydronaphthalenes |
DE3506117A1 (de) * | 1985-02-22 | 1986-08-28 | Basf Ag, 6700 Ludwigshafen | Amine, verfahren zu ihrer herstellung und ihre verwendung als fungizide |
-
1992
- 1992-06-26 IT ITMI921569A patent/IT1255178B/it active IP Right Grant
-
1993
- 1993-06-22 ZA ZA934472A patent/ZA934472B/xx unknown
- 1993-06-22 JP JP6502035A patent/JPH07508514A/ja active Pending
- 1993-06-22 AU AU44195/93A patent/AU670444B2/en not_active Ceased
- 1993-06-22 RU RU94046220A patent/RU2115651C1/ru active
- 1993-06-22 NZ NZ253689A patent/NZ253689A/en unknown
- 1993-06-22 HU HU9403768A patent/HUT71405A/hu unknown
- 1993-06-22 WO PCT/EP1993/001589 patent/WO1994000441A1/en not_active Application Discontinuation
- 1993-06-22 EP EP93914690A patent/EP0647222A1/en not_active Withdrawn
- 1993-06-22 CA CA002137685A patent/CA2137685A1/en not_active Abandoned
- 1993-06-24 IL IL106124A patent/IL106124A/en not_active IP Right Cessation
-
1994
- 1994-12-21 FI FI945997A patent/FI945997A0/fi unknown
- 1994-12-26 KR KR1019940704767A patent/KR950702195A/ko not_active Application Discontinuation
Non-Patent Citations (1)
Title |
---|
EP, A, 0193065, кл. 265/30, 1986. US, патент, 4473586, кл. 514 - 605, 1984. * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2641648C1 (ru) * | 2009-12-04 | 2018-01-19 | Суновион Фармасьютикалз, Инк. | Полициклические соединения и способы их применения |
Also Published As
Publication number | Publication date |
---|---|
HUT71405A (en) | 1995-11-28 |
IT1255178B (it) | 1995-10-20 |
AU4419593A (en) | 1994-01-24 |
EP0647222A1 (en) | 1995-04-12 |
KR950702195A (ko) | 1995-06-19 |
FI945997A (fi) | 1994-12-21 |
AU670444B2 (en) | 1996-07-18 |
JPH07508514A (ja) | 1995-09-21 |
IL106124A (en) | 1998-02-22 |
HU9403768D0 (en) | 1995-02-28 |
ITMI921569A1 (it) | 1993-12-26 |
CA2137685A1 (en) | 1994-01-06 |
NZ253689A (en) | 1996-11-26 |
ITMI921569A0 (it) | 1992-06-26 |
FI945997A0 (fi) | 1994-12-21 |
WO1994000441A1 (en) | 1994-01-06 |
RU94046220A (ru) | 1996-09-27 |
ZA934472B (en) | 1994-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2115651C1 (ru) | N(гетеро)-арил-n(гетеро)-тетралин-алкил-пиперазины, способ их получения | |
US4234585A (en) | 1,2-Dihydroquinoline-2-one derivatives | |
Boekelheide et al. | Reissert Compounds. Further Alkylation Studies and a Novel Rearrangement1 | |
HUT72656A (en) | Inhibitors of c-amp phosphodiesterase and tnf, their preparation pharmaceuticals contg. them and their use | |
NO792020L (no) | Fremgangsmaate for fremstilling av farmakologisk aktive fenylpiperaziner | |
KR20000022380A (ko) | 무스카린 길항제 | |
Archer et al. | The preparation of some 1-alkylamino-and dialkylaminoalkylaminothiaxanthones1 | |
DE602006000102T2 (de) | Indanyl-piperazinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
JPH07110857B2 (ja) | ピペラジニル置換およびピペリジニル置換シクロヘキセンおよびシクロヘキサン誘導体 | |
CA1072095A (en) | Phenyl piperazine olefins | |
EP0212481B1 (de) | Indolinonderivate, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und deren Verwendung | |
JPS6139289B2 (it) | ||
US3305553A (en) | 2-aminoquinazoline derivatives | |
US2554737A (en) | Basically substituted tetrahydroquinoline derivatives | |
US2943090A (en) | Substituted piperazines and method of preparing the same | |
CH617934A5 (it) | ||
DD258984A5 (de) | Verfahren zur herstellung neuer heterozyklischer carboxamid-derivate | |
US2553093A (en) | Aminoalkylethanesulfonamide | |
HU187572B (en) | Process for preparing 1,5-diphenyl-pyrazolin-3-one derivatives | |
US4963680A (en) | Piperazine derivatives and their preparation process | |
CA1056834A (en) | 3-(4-bromophenyl)-n-methyl-3-(3-pyridyl)-allylamine | |
EP0099017A2 (de) | Neue Phenylessigsäure-Derivate, ihre Herstellung und diese Verbindungen enthaltende Arzneimittel | |
Surrey et al. | New Amorbacides--VI. The Preparation of some N, N'-Disubstituted-N, N'-bis (haloacyl)-1, 4-xylylenediamines | |
Engelhardt et al. | Antidepressants. Tetrabenazine-antagonizing activity in a series of 5H-dibenzo [cycloheptene-5-propylamines | |
DE2412520A1 (de) | Tricyclische verbindungen |